Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

13.63
Delayed Data
As of 2:19pm ET
 -0.125 / -0.91%
Today’s Change
2.65
Today|||52-Week Range
15.05
+346.72%
Year-to-Date

Today’s Trading

Previous close13.75
Today’s open13.90
Day’s range13.45 - 13.95
Volume1,314,774
Average volume (3 months)1,495,911
Market cap$1.1B
Dividend yield--
Data as of 2:19pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)+16.26%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book7.16

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd+0.02+0.06%
EPZMEpizyme Inc-0.35-2.06%
FPRXFive Prime Therapeut...+0.70+1.98%
MNTAMomenta Pharmaceutic...+0.25+1.46%
Data as of 2:34pm ET, 09/25/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts